-
Publication Venue For
-
Further evidence for the use of aspirin in COVID-19..
346:107-108.
2022
-
Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis..
346:30-34.
2022
-
Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure..
345:54-60.
2021
-
Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis..
344:54-59.
2021
-
Thirty-day outcomes and predictors of mortality following acute myocardial infarction in northern Tanzania: A prospective observational cohort study..
342:23-28.
2021
-
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry..
340:96-104.
2021
-
The right atrium, more than a storehouse..
331:329-330.
2021
-
Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study..
330:251-258.
2021
-
Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke..
321:88-94.
2020
-
A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation..
319:85-93.
2020
-
Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trial..
318:7-13.
2020
-
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries..
311:7-14.
2020
-
A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia..
309:95-99.
2020
-
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial..
302:53-58.
2020
-
Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group..
296:65-70.
2019
-
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial..
291:36-41.
2019
-
Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension..
291:134-139.
2019
-
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes..
289:58-62.
2019
-
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events..
289:138-143.
2019
-
Duration and complications of diabetes mellitus and the associated risk of infective endocarditis..
278:280-284.
2019
-
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention..
275:31-35.
2019
-
Incremental prognostic value of renal function for stroke prediction in atrial fibrillation..
274:152-157.
2019
-
Seasonal and circadian patterns of myocardial infarction by coronary artery disease status and sex in the ACTION Registry-GWTG..
274:16-20.
2019
-
Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury..
271:240-246.
2018
-
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials..
270:96-101.
2018
-
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe..
270:245-252.
2018
-
Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis..
269:292-297.
2018
-
Improvement in quality indicators using NCDR® registries: First international experience..
267:13-15.
2018
-
Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study..
264:12-17.
2018
-
Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice..
261:99-100.
2018
-
Systematic review and directors survey of quality indicators for the cardiovascular intensive care unit..
260:219-225.
2018
-
Two-dimensional global longitudinal strain is superior to left ventricular ejection fraction in prediction of outcome in patients with left-sided infective endocarditis..
260:118-123.
2018
-
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure..
258:185-191.
2018
-
Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA)..
257:318-323.
2018
-
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF..
257:78-83.
2018
-
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF..
253:91-96.
2018
-
Identification of patients with stable chest pain deriving minimal value from coronary computed tomography angiography: An external validation of the PROMISE minimal-risk tool..
252:31-34.
2018
-
The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry..
252:117-121.
2018
-
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study..
248:414-420.
2017
-
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis..
241:87-96.
2017
-
Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) study..
241:70-75.
2017
-
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study..
236:54-60.
2017
-
Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency..
231:255-257.
2017
-
Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review..
230:301-303.
2017
-
Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology..
230:384-401.
2017
-
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy..
228:459-464.
2017
-
Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial..
227:443-449.
2017
-
A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade..
224:33-36.
2016
-
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation..
224:206-212.
2016
-
Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure..
224:231-239.
2016
-
A Brazilian perspective for the use of bovine heparin in open heart surgery..
223:611-612.
2016
-
Clinical and geographic patterns of rheumatic heart disease in outpatients attending cardiology clinic in western Kenya..
223:228-235.
2016
-
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial..
223:967-975.
2016
-
Acute heart failure in the young: Clinical characteristics and biomarker profiles..
221:1067-1072.
2016
-
A plausible causal link between antiretroviral therapy and increased blood pressure in a sub-Saharan African setting: A propensity score-matched analysis..
220:400-407.
2016
-
Importance of papillary muscle infarction detected by cardiac magnetic resonance imaging in predicting cardiovascular events..
220:558-563.
2016
-
Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current..
220:290-298.
2016
-
Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events..
218:291-297.
2016
-
Evolution of hypertrophic cardiomyopathy assessed using serial cardiovascular magnetic resonance imaging..
216:156-158.
2016
-
Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors..
215:201-208.
2016
-
Neural modulation for hypertension and heart failure..
214:320-330.
2016
-
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients..
204:164-171.
2016
-
The metabolic syndrome, coronary artery calcium score and cardiovascular risk reclassification..
204:81-82.
2016
-
Appropriateness of cardiac stress test use among primary care physicians and cardiologists in the United States..
203:584-586.
2016
-
Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions..
203:708-713.
2016
-
Giant mitral blood cyst: Cardiovascular magnetic resonance imaging features..
203:17-18.
2016
-
MicroRNAs relate to early worsening of renal function in patients with acute heart failure..
203:564-569.
2016
-
Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study..
202:349-355.
2016
-
Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial..
202:589-594.
2016
-
Projected morbidity and mortality from missed diagnoses of coronary artery disease in the United States..
195:250-252.
2015
-
Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI..
195:136-142.
2015
-
Atherosclerosis: Recent trials, new targets and future directions..
192:72-81.
2015
-
A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study..
185:313-319.
2015
-
Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease..
184:108-114.
2015
-
Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial..
182:184-186.
2015
-
Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis..
182:387-389.
2015
-
Q wave myocardial infarction of anteroseptal zone: a new classification..
180:44-45.
2015
-
One-year outcome following biological or mechanical valve replacement for infective endocarditis..
178:117-123.
2015
-
Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program..
189:141-147.
2015
-
Efficacy of cilostazol on inhibition of platelet aggregation, inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention: The ACCEL-LOADING-ACS (ACCELerated Inhibition of Platelet Aggregation, Inflammation and Myonecrosis by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome) study..
190:370-375.
2015
-
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial..
189:272-278.
2015
-
Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF..
177:840-846.
2014
-
Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review..
177:990-994.
2014
-
The association between meteorological events and acute heart failure: new insights from ASCEND-HF..
177:819-824.
2014
-
Accuracy of multidetector computed tomography for detection of coronary artery stenosis in acute coronary syndrome compared with stable coronary disease: a CORE64 multicenter trial substudy..
177:385-391.
2014
-
Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial..
176:1126-1128.
2014
-
IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry..
176:1006-1008.
2014
-
International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries..
175:240-247.
2014
-
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis..
174:683-687.
2014
-
Influence of exercise training on T-wave alternans assessed during exercise test in heart failure patients..
174:747-749.
2014
-
Pharmacodynamic efficacy and safety of adjunctive cilostazol loading to clopidogrel and aspirin loading: the results of the ACCEL-LOADING (Accelerated Platelet Inhibition by Cilostazol Loading) study..
174:129-132.
2014
-
Prescribing warfarin at discharge for heart failure patients: findings from the Get With The Guidelines-Heart Failure Registry..
172:e322-e323.
2014
-
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?.
172:253-254.
2014
-
Galen, father of systematic medicine. An essay on the evolution of modern medicine and cardiology..
172:47-58.
2014
-
Cinacalcet ameliorates cardiac fibrosis in uremic hearts through suppression of endothelial-to-mesenchymal transition..
171:e65-e69.
2014
-
Response to the Letter to the Editor titled "Atrial fibrillation in patients with acute coronary syndromes"..
171:e106.
2014
-
Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training..
171:e50-e51.
2014
-
Historical continuity in the methodology of modern medical science: Leonardo leads the way..
171:103-115.
2014
-
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry..
170:413-418.
2014
-
Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013..
170:e59-e62.
2014
-
Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial..
170:215-220.
2013
-
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?.
168:5437-5447.
2013
-
Anger control and cardiovascular outcomes..
168:4338-4339.
2013
-
Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION study..
168:4357-4359.
2013
-
Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease..
168:4584-4585.
2013
-
Greek underpinnings to his methodology in unraveling De Motu Cordis and what Harvey has to teach us still today..
168:3173-3182.
2013
-
Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome"..
168:4543.
2013
-
Carotid body removal for treatment of chronic systolic heart failure..
168:2506-2509.
2013
-
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes..
168:2510-2517.
2013
-
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy..
168:2127-2133.
2013
-
The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials..
168:2816-2824.
2013
-
The relationship between meteorological conditions and index acute coronary events in a global clinical trial..
168:2315-2321.
2013
-
Influence of platelet reactivity and inflammation on peri-procedural myonecrosis in East Asian patients undergoing elective percutaneous coronary intervention..
168:427-435.
2013
-
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial..
167:2580-2587.
2013
-
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges..
167:1772-1782.
2013
-
The past, present and future of renin-angiotensin aldosterone system inhibition..
167:1677-1687.
2013
-
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years..
167:548-554.
2013
-
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial..
167:151-156.
2013
-
Diagnostic accuracy of coronary artery calcium for obstructive disease: results from the ACCURACY trial..
166:505-508.
2013
-
Comparison of image characteristics of plaques in culprit coronary arteries by 64 slice CT and intravascular ultrasound in acute coronary syndromes..
160:119-126.
2012
-
Caution in interpreting the findings from small observational studies..
160:71.
2012
-
Differences in coronary plaque composition with aging measured by coronary computed tomography angiography..
158:240-245.
2012
-
"Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is... "..
152:387.
2011
-
Association of anemia and long-term survival in patients with pulmonary hypertension..
150:291-295.
2011
-
Patterns of leukocyte counts on admissions for acute heart failure--presentation and outcome--results from a community based registry..
148:17-22.
2011
-
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy..
144:175-179.
2010
-
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY..
144:36-41.
2010
-
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial..
139:123-133.
2010
-
Cataloguing the geometry of the human coronary arteries: a potential tool for predicting risk of coronary artery disease..
135:43-52.
2009
-
An unusual case of partial anomalous pulmonary venous drainage: utility of the cardiac MRI..
133:e35-e36.
2009
-
Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis..
130:220-226.
2008
-
Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena..
115:e8-e9.
2007
-
Training of interventional cardiologists in radiation protection--the IAEA's initiatives..
114:256-260.
2007
-
Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.
2017
-
From abstract to peer-reviewed publication: country matters.
2014